Radiofrequency Ablation (RFA) of Primary or Metastatic Liver Tumors

Radiofrequency ablation (RFA) of primary or metastatic liver tumors for treatment of inoperable hepatocellular carcinoma (single lesion ≤5 cm or up to 3 nodules <3 cm), as a bridge to transplant, and for hepatic metastases primarily from colorectal cancer or select neuroendocrine tumors when surgical resection is not feasible. Coverage requires lesions be inoperable and meet size/number criteria, excludes cases with extrahepatic disease or operable HCC, and considers use outside these limits (e.g., other primaries, >3 nodules, larger tumors) experimental/investigational; member benefit plans and state rules govern final coverage.

"Radiofrequency ablation (RFA) for primary or metastatic liver tumors when surgical resection is not feasible (e."

Sign up to see full coverage criteria, indications, and limitations.